Drugs to treat the novel coronavirus could be available by this summer or fall, US Vice President Mike Pence said Monday.
"The vaccine may not be available until late this year or early next, but the therapeutics to give relief to the people who contract the coronavirus could be available by summer or early fall," he told a news conference.
The Gilead drug remdesivir has already been used to treat one infected patient in the US as part of a trial, and the intravenous antiviral is also being deployed in trials in Asia.
Other notable potential treatments include one being developed by Regeneron that uses monoclonal antibodies to fight the infection. The same strategy has been shown to be effective against Ebola.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
